Accessibility

Author name: Genome Alberta

A Groundbreaking Data Resource is Transforming the Fight Against Antibiotic-Resistant Bacteria

How do you defeat an enemy you don’t understand, and who adapts to your every move? This is the serious challenge facing all modern medicine as doctors and scientists fight against antibiotic-resistant bacteria. As genetic sequencing has historically been too impractical to conduct for each patient’s infection, doctors typically apply antibiotics right away rather than

A Groundbreaking Data Resource is Transforming the Fight Against Antibiotic-Resistant Bacteria Read More »

Top Innovators Recognized at 37th Annual ASTech Awards

Each fall, the Alberta Science and Technology Awards, or ASTech Awards, recognize Alberta’s most innovative individuals, teams and organizations for their contributions to science, technology and innovation. This year, finalists came together at the Opening Ceremonies in Calgary on September 18, 2026 and winners were announced at the Awards Gala in Edmonton on November 6,

Top Innovators Recognized at 37th Annual ASTech Awards Read More »

Headshot of Dr. David Bailey

Genome Alberta CEO, Dr. David Bailey, Inducted into the Canadian Agricultural Hall of Fame

On November 7, 2026, the Canadian Agricultural Hall of Fame celebrated five new inductees, including Genome Alberta’s President and CEO, Dr. David Bailey. This honour recognizes his more than 40 years of contributions to agricultural research, food safety and the application of genomics in Canadian agriculture. David’s interest in genetics began on a beef farm

Genome Alberta CEO, Dr. David Bailey, Inducted into the Canadian Agricultural Hall of Fame Read More »

Data Projects to Deliver Practical Tools for Alberta Producers

Seven new projects will use genomics data, AI and advanced analytics to improve livestock productivity, manage crop disease and pests, support pollinator health and strengthen antimicrobial resistance surveillance.   Calgary, Alberta – September 28, 2026 – Genome Alberta, with support from the Government of Alberta, is pleased to announce seven new projects with a total

Data Projects to Deliver Practical Tools for Alberta Producers Read More »

Graphic saying "New Work Placement Programs Announced"

Genome Alberta to Advance Innovation Through Work Placements at Biotech Companies

Edmonton, Alberta – September 24, 2026 – Today, the Government of Alberta announced an additional $1 million investment from 2026-2029 for Genome Alberta’s work placement programs. This investment will create new roles for skilled talent at 18-20 Alberta small and medium-sized businesses to develop and scale new genomics technologies. Alberta has a rapidly expanding life sciences

Genome Alberta to Advance Innovation Through Work Placements at Biotech Companies Read More »

Design showing headshots of the 5 new board members.

Genome Alberta Welcomes Five New Board Members

Appointments bring broad expertise in innovation, commercialization, public policy and agriculture.   CALGARY, AB – August 25, 2026 – Genome Alberta is pleased to announce the appointment of five new members to its Board of Directors. Allison Swelin, Curtis Clarke, John Wilson, Virgil Lowe and Camille Ryan were appointed following the organization’s Annual General Meeting

Genome Alberta Welcomes Five New Board Members Read More »

From Discovery to Market III: Rapid Infection Diagnostics Inc.

The Commercialization Gap Is Real: Rapid Infection Diagnostics Shows Why Early Investment Matters   For most startups, securing enough capital to move from research to commercialization is one of the greatest challenges they will face. For Alberta-based Rapid Infection Diagnostics Inc. (RID), that journey has taken more than a decade, required nearly $20 million in

From Discovery to Market III: Rapid Infection Diagnostics Inc. Read More »

Connecting New Business Grads With Genomics Innovators

Genomic tools and technologies have the potential to improve our health, environment and nutrition, and Alberta has no shortage of entrepreneurs ready to meet the challenge. However, while biotech startups are typically well-equipped to test and refine their technologies and products, scaling-up into a sustainable business presents a wholly new challenge. A 2025 survey conducted

Connecting New Business Grads With Genomics Innovators Read More »

From Discovery to Market II: Nova Medical Testing Inc.

From Lab Discovery to Global Impact: How Nova Medical Testing Inc. is Advancing Metabolomics in Alberta and Beyond   In the world of life sciences, timing is everything. While genomics can help predict what might happen in the body, metabolomics reveals what has already happened and provides a powerful perspective that is becoming increasingly important

From Discovery to Market II: Nova Medical Testing Inc. Read More »

From Discovery to Market I: Luminous BioSolutions Inc.

Lighting the Way: A Calgary Startup Tackles One of Canada’s Biggest Environmental Challenges   In northern Alberta, one of the most complex environmental challenges in the world continues to grow quietly but persistently. More than a trillion litres of oil sands tailings water sit across vast landscapes, awaiting a viable path to treatment and eventual

From Discovery to Market I: Luminous BioSolutions Inc. Read More »

Scroll to Top
Share
Copy Link